Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1998-1-20
pubmed:abstractText
The aim of the present study was to delineate the functional domains of nociceptin (noc), a neuropeptide which is structurally related to dynorphin A (dyn). The binding and biological potencies towards the nociceptin (ORL1) and dynorphin A (kappa-opioid) receptors of twenty dyn/noc and noc/dyn hybrid peptides were compared with those of the parent heptadecapeptides. Replacement of as many as eleven residues in the C-terminus of dynorphin by the corresponding nociceptin sequence has no significant effect on binding and biological activity towards the kappa-opioid receptor. In marked contrast, replacement of as few as six residues (RKLANQ) in the C-terminus of nociceptin by the corresponding dynorphin sequence (LKWDNQ) dramatically impairs both affinity and activity towards the ORL1 receptor. This clearly indicates that the two neuropeptides have different functional architectures, despite the dual structural homology of both ligands and receptors. Moreover, the recombinant peptide approach led us to identify hybrids whose sequences differ only at positions 5 and 6 and displaying opposite or no receptor selectivity. One contains the dynorphin Leu5-Arg6 sequence and prefers the kappa-opioid receptor, whereas the other comprises the nociceptin Thr5-Gly6 sequence and prefers the ORL1 receptor. A third, containing the mixed dynorphin/nociceptin Leu5-Gly6 sequence, does not discriminate between the two types of receptor.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0014-5793
pubmed:author
pubmed:issnType
Print
pubmed:day
17
pubmed:volume
417
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
333-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9409745-Amino Acid Sequence, pubmed-meshheading:9409745-Animals, pubmed-meshheading:9409745-Binding, Competitive, pubmed-meshheading:9409745-CHO Cells, pubmed-meshheading:9409745-Cell Membrane, pubmed-meshheading:9409745-Cricetinae, pubmed-meshheading:9409745-Diprenorphine, pubmed-meshheading:9409745-Dynorphins, pubmed-meshheading:9409745-Humans, pubmed-meshheading:9409745-Kinetics, pubmed-meshheading:9409745-Molecular Sequence Data, pubmed-meshheading:9409745-Opioid Peptides, pubmed-meshheading:9409745-Peptides, pubmed-meshheading:9409745-Receptors, Opioid, pubmed-meshheading:9409745-Receptors, Opioid, kappa, pubmed-meshheading:9409745-Recombinant Fusion Proteins, pubmed-meshheading:9409745-Recombinant Proteins, pubmed-meshheading:9409745-Sequence Alignment, pubmed-meshheading:9409745-Structure-Activity Relationship
pubmed:year
1997
pubmed:articleTitle
Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
pubmed:affiliation
Unité de Neuropharmacologie Moléculaire, Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Toulouse, France.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't